Patients presenting to the Paediatric Emergency Department.
Medical and nursing staff in the Paediatric Emergency Department.
November 2023: This guidance is currently under review as it has gone beyond the standard review date. It reflects best practice at the time of authorship / last review and remains safe for use. If there are any concerns regarding the content then please consult with senior clinical staff to confirm.
For example:
No Pain | Mild Pain | Moderate Pain | Severe Pain | |
Behaviour | Normal activity No↓ in movement Happy |
Rubbing affected area Decreased movement Neutral expression Able to talk/play normally |
Protective of affected area ↓movement / quiet Complaining of pain Consolable crying Grimaces when affected part moved / touched |
No movement or defensive of affected part Looking frightened Very quiet Restless, unsettled Complaining of lots of pain Inconsolable crying |
Injury example* | Abrasion / small laceration Ankle sprain Minor head injury |
Small burn / scald Undisplaced limb # Fingertip injury Appendicitis |
Displaced limb # # dislocation Larger burns/scalds Appendicitis Sickle crisis |
* Example of injury is only intended as a guide – cases should be assessed on an individual basis
If child is being admitted and is likely to need ongoing analgesia for moderate / severe pain, consider contacting pain relief nurse specialist (page 8133/ ext. 86920) or duty anaesthetist (page 8602).
- to be used in conjunction with Emergency Department Pain Management guideline
To be included as part of the first-line treatment of severe pain in a child (without IV access).
For example, in children with pain secondary to:
- Clinically suspected limb fractures
- Painful/distressing burns
Dose = approximately 1.5 micrograms/kg (repeat after 30mins if needed)
Preparation: Fentanyl injection 50 micrograms in 1ml (CD) (dilution not required)
Weight of child (kg) |
Dose (micrograms) |
Dose volume (to 1 decimal place) |
10 |
15 |
0.3 ml |
13 |
20 |
0.4 ml |
15 |
25 |
0.5 ml |
20 |
30 |
0.6 ml |
25 |
40 |
0.8 ml |
30 |
45 |
0.9 ml |
35 |
55 |
1.1 ml |
40 |
60 |
1.2 ml |
45 |
70 |
1.4 ml |
50 |
75 |
1.5 ml |
55 |
85 |
1.7 ml |
60 |
90 |
1.8 ml |
Approved by RHC ED Consultant group with approval from RHC Drugs and Therapeutics Committee pending: February 2022
Last reviewed: 09 February 2022
Next review: 30 April 2024
Author(s): Dr Joanne Stirling (Consultant in Paediatric Emergency Medicine, RHCG), Correspondence author - Dr Steve Foster (Consultant in Paediatric Emergency Medicine, RHCG)
Co-Author(s): Stakeholder: Mr Stephen Bowhay (Lead Clinical Pharmacist, RHCG)
Approved By: Paediatric Drugs and Therapeutics Committee, RHCG. RHC ED clinical governance group, RHCG